Labviva

About Labviva

Labviva is a life sciences purchasing and inventory platform with a mission to unify the life sciences supply chain. Its AI-native platform empowers purchasing departments, researchers, and lab operations to control costs, streamline procurement, and keep research on track, achieving significant savings (up to 20% in the first year) through competitive pricing and transparency.

Products & Services

Purchasing Platform:Integrates with enterprise procurement systems to optimize spend and purchasing channels, offering control over supplier networks and data transparency, resulting in average savings of 20% in the first year.

Inventory Management System:Provides automated control and visibility over stockroom shelves, reducing admin time and sourcing costs by up to 41% while managing compliance.

Dashboard & Analytics:Offers real-time, consolidated views of R&D purchasing data with customizable reporting and filters to track spend and forecast inventory needs.

Harper Scientific Selectors:A scientist-centric tool for sourcing chemicals, antibodies, and bioreagents through a modern eCommerce interface within the Purchasing Platform.

Solutions for Researchers & Labs:Simplifies procurement and operations to accelerate life sciences research.

Solutions for Suppliers:Enables suppliers to sell on the Labviva Platform, grow eCommerce business, and connect with consumers.

Solutions for Purchasers:Reduces R&D spend with greater visibility and control over purchasing.

Integrations:Seamlessly integrates multiple catalogs into ERP systems with a single interface.

Specialties

Purchasing Platform for Life Sciences Inventory Management Automation AI-Native Procurement Solutions R&D Spend Optimization Supply Chain Transparency

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-01-13 FD: 2025-01-13	4 investors
2	RT: Series A T: - FT: Series A	A: 20000000 MR: - FA: $20 million FAN: 20000000	D: 2023-03-27 FD: 2023-03-27	4 investors

Series B Latest

2025-01-13

$25.0M

4 investors (Pro only)

Series A 2023-03-27

$20.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Siamak Baharloo

Co-founder & CEO

LinkedIn (Pro only)

N

Nicholas Rioux

Co-founder and CTO

LinkedIn (Pro only)

R

Renika Sehgal

COO & CFO

LinkedIn (Pro only)

J

Jennifer Olszewski

CMO

C

Carlo Iannicola

General Manager, Europe

N

Nick Premnath

SVP of Commercial Strategy

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Labviva Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

About Labviva

Products & Services

Specialties

Funding History

Growth Metrics

Team & Leadership

Recent News

Labviva Announces New Product Launch

Leadership Team Expands with Industry Veteran

Company Recognized as Industry Leader

Key Competitors

Competitor Alpha

Competitor Beta

Competitor Gamma

Competitor Delta

Company Details

Similar Companies

Technology Stack